Skip to main content
Premium Trial:

Request an Annual Quote

Irene Hrusovsky, Gary Alianell, James Prudent

Premium

Bioinformatics and nucleic acid design startup EraGen Biosciences of Madison, Wisc., has named Irene Hrusovsky as its president and chief executive officer. Hrusovsky comes to EraGen from GlaxoSmithKline, where she served as vice president of general medicine/medical marketing strategy/clinical operations. Previously, Hrusovsky worked for over 20 years at Abbott Laboratories in diagnostics, pharmaceuticals, and business development management positions. Hrusovsky, who is a board-certified pediatrician, received her MD at the University of British Columbia, and her pediatric training at Ohio State University.

Hrusovsky joins an executive team made of chief operating officer Gary Alianell, who holds a PhD in molecular genetics from the University of South Carolina, and chief scientific officer James Prudent, the co-inventor of Third Wave’s Invader technology.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.